Tian, Lei
Xu, Bo
Chen, Yuqing https://orcid.org/0000-0003-0649-530X
Li, Zhenlong
Wang, Jing
Zhang, Jianying
Ma, Rui
Cao, Shuai
Hu, Weidong
Chiocca, E. Antonio
Kaur, Balveen
Caligiuri, Michael A. https://orcid.org/0000-0002-4095-3020
Yu, Jianhua https://orcid.org/0000-0002-0326-3223
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA210087, CA265095, CA163205, CA247550, CA264512, CA266457, CA223400)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS106170)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI129582)
Leukemia and Lymphoma Society (1364-19)
Article History
Received: 18 April 2021
Accepted: 20 September 2022
First Online: 10 November 2022
Competing interests
: M.A.C., J.Y., L.T., B.K. and E.A.C. have relevant or nonrelevant oncolytic virus patents awarded or pending. The remaining authors declare no competing interests.